Global Ophthalmic Medicine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Ophthalmic Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Medicine players cover Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV and Mentholatum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
LPI (LP Information)' newest research report, the “Ophthalmic Medicine Industry Forecast” looks at past sales and reviews total world Ophthalmic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Medicine sales for 2023 through 2029. With Ophthalmic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Ophthalmic Medicine market?
What factors are driving Ophthalmic Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Medicine market opportunities vary by end market size?
How does Ophthalmic Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Ophthalmic Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Medicine players cover Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV and Mentholatum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
LPI (LP Information)' newest research report, the “Ophthalmic Medicine Industry Forecast” looks at past sales and reviews total world Ophthalmic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Medicine sales for 2023 through 2029. With Ophthalmic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Eye Drops
- Eye Ointment
- Gelling Agent
- Tablet
- Injection
- Anti-fatigue and Dryness
- Cataract
- Anti-infective
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novaliq
- Shenyang Xingqi Pharmaceutical Co.,Ltd.
- Zhejiang Shapuaisi Pharmaceutical
- Chengdu Kanghong Pharmaceutical Group
- Santen Pharmaceutica
- Bausch Health
- Alcon NV
- Mentholatum
What is the 10-year outlook for the global Ophthalmic Medicine market?
What factors are driving Ophthalmic Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Medicine market opportunities vary by end market size?
How does Ophthalmic Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ophthalmic Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ophthalmic Medicine by Country/Region, 2018, 2022 & 2029
2.2 Ophthalmic Medicine Segment by Type
2.2.1 Eye Drops
2.2.2 Eye Ointment
2.2.3 Gelling Agent
2.2.4 Tablet
2.2.5 Injection
2.3 Ophthalmic Medicine Sales by Type
2.3.1 Global Ophthalmic Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ophthalmic Medicine Sale Price by Type (2018-2023)
2.4 Ophthalmic Medicine Segment by Application
2.4.1 Anti-fatigue and Dryness
2.4.2 Cataract
2.4.3 Anti-infective
2.5 Ophthalmic Medicine Sales by Application
2.5.1 Global Ophthalmic Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Ophthalmic Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ophthalmic Medicine Sale Price by Application (2018-2023)
3 GLOBAL OPHTHALMIC MEDICINE BY COMPANY
3.1 Global Ophthalmic Medicine Breakdown Data by Company
3.1.1 Global Ophthalmic Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Ophthalmic Medicine Sales Market Share by Company (2018-2023)
3.2 Global Ophthalmic Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Ophthalmic Medicine Revenue by Company (2018-2023)
3.2.2 Global Ophthalmic Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Ophthalmic Medicine Sale Price by Company
3.4 Key Manufacturers Ophthalmic Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Medicine Product Location Distribution
3.4.2 Players Ophthalmic Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Ophthalmic Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ophthalmic Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ophthalmic Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Ophthalmic Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ophthalmic Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ophthalmic Medicine Sales Growth
4.4 APAC Ophthalmic Medicine Sales Growth
4.5 Europe Ophthalmic Medicine Sales Growth
4.6 Middle East & Africa Ophthalmic Medicine Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Medicine Sales by Country
5.1.1 Americas Ophthalmic Medicine Sales by Country (2018-2023)
5.1.2 Americas Ophthalmic Medicine Revenue by Country (2018-2023)
5.2 Americas Ophthalmic Medicine Sales by Type
5.3 Americas Ophthalmic Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Medicine Sales by Region
6.1.1 APAC Ophthalmic Medicine Sales by Region (2018-2023)
6.1.2 APAC Ophthalmic Medicine Revenue by Region (2018-2023)
6.2 APAC Ophthalmic Medicine Sales by Type
6.3 APAC Ophthalmic Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Medicine by Country
7.1.1 Europe Ophthalmic Medicine Sales by Country (2018-2023)
7.1.2 Europe Ophthalmic Medicine Revenue by Country (2018-2023)
7.2 Europe Ophthalmic Medicine Sales by Type
7.3 Europe Ophthalmic Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Medicine by Country
8.1.1 Middle East & Africa Ophthalmic Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ophthalmic Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Ophthalmic Medicine Sales by Type
8.3 Middle East & Africa Ophthalmic Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Medicine
10.3 Manufacturing Process Analysis of Ophthalmic Medicine
10.4 Industry Chain Structure of Ophthalmic Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Medicine Distributors
11.3 Ophthalmic Medicine Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC MEDICINE BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Medicine Market Size Forecast by Region
12.1.1 Global Ophthalmic Medicine Forecast by Region (2024-2029)
12.1.2 Global Ophthalmic Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Medicine Forecast by Type
12.7 Global Ophthalmic Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novaliq
13.1.1 Novaliq Company Information
13.1.2 Novaliq Ophthalmic Medicine Product Portfolios and Specifications
13.1.3 Novaliq Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novaliq Main Business Overview
13.1.5 Novaliq Latest Developments
13.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
13.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
13.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolios and Specifications
13.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
13.3 Zhejiang Shapuaisi Pharmaceutical
13.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
13.3.2 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolios and Specifications
13.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhejiang Shapuaisi Pharmaceutical Main Business Overview
13.3.5 Zhejiang Shapuaisi Pharmaceutical Latest Developments
13.4 Chengdu Kanghong Pharmaceutical Group
13.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.4.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolios and Specifications
13.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.4.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
13.5 Santen Pharmaceutica
13.5.1 Santen Pharmaceutica Company Information
13.5.2 Santen Pharmaceutica Ophthalmic Medicine Product Portfolios and Specifications
13.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Santen Pharmaceutica Main Business Overview
13.5.5 Santen Pharmaceutica Latest Developments
13.6 Bausch Health
13.6.1 Bausch Health Company Information
13.6.2 Bausch Health Ophthalmic Medicine Product Portfolios and Specifications
13.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bausch Health Main Business Overview
13.6.5 Bausch Health Latest Developments
13.7 Alcon NV
13.7.1 Alcon NV Company Information
13.7.2 Alcon NV Ophthalmic Medicine Product Portfolios and Specifications
13.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Alcon NV Main Business Overview
13.7.5 Alcon NV Latest Developments
13.8 Mentholatum
13.8.1 Mentholatum Company Information
13.8.2 Mentholatum Ophthalmic Medicine Product Portfolios and Specifications
13.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mentholatum Main Business Overview
13.8.5 Mentholatum Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ophthalmic Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ophthalmic Medicine by Country/Region, 2018, 2022 & 2029
2.2 Ophthalmic Medicine Segment by Type
2.2.1 Eye Drops
2.2.2 Eye Ointment
2.2.3 Gelling Agent
2.2.4 Tablet
2.2.5 Injection
2.3 Ophthalmic Medicine Sales by Type
2.3.1 Global Ophthalmic Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ophthalmic Medicine Sale Price by Type (2018-2023)
2.4 Ophthalmic Medicine Segment by Application
2.4.1 Anti-fatigue and Dryness
2.4.2 Cataract
2.4.3 Anti-infective
2.5 Ophthalmic Medicine Sales by Application
2.5.1 Global Ophthalmic Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Ophthalmic Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ophthalmic Medicine Sale Price by Application (2018-2023)
3 GLOBAL OPHTHALMIC MEDICINE BY COMPANY
3.1 Global Ophthalmic Medicine Breakdown Data by Company
3.1.1 Global Ophthalmic Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Ophthalmic Medicine Sales Market Share by Company (2018-2023)
3.2 Global Ophthalmic Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Ophthalmic Medicine Revenue by Company (2018-2023)
3.2.2 Global Ophthalmic Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Ophthalmic Medicine Sale Price by Company
3.4 Key Manufacturers Ophthalmic Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Medicine Product Location Distribution
3.4.2 Players Ophthalmic Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Ophthalmic Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ophthalmic Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ophthalmic Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Ophthalmic Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ophthalmic Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ophthalmic Medicine Sales Growth
4.4 APAC Ophthalmic Medicine Sales Growth
4.5 Europe Ophthalmic Medicine Sales Growth
4.6 Middle East & Africa Ophthalmic Medicine Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Medicine Sales by Country
5.1.1 Americas Ophthalmic Medicine Sales by Country (2018-2023)
5.1.2 Americas Ophthalmic Medicine Revenue by Country (2018-2023)
5.2 Americas Ophthalmic Medicine Sales by Type
5.3 Americas Ophthalmic Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Medicine Sales by Region
6.1.1 APAC Ophthalmic Medicine Sales by Region (2018-2023)
6.1.2 APAC Ophthalmic Medicine Revenue by Region (2018-2023)
6.2 APAC Ophthalmic Medicine Sales by Type
6.3 APAC Ophthalmic Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Medicine by Country
7.1.1 Europe Ophthalmic Medicine Sales by Country (2018-2023)
7.1.2 Europe Ophthalmic Medicine Revenue by Country (2018-2023)
7.2 Europe Ophthalmic Medicine Sales by Type
7.3 Europe Ophthalmic Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Medicine by Country
8.1.1 Middle East & Africa Ophthalmic Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ophthalmic Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Ophthalmic Medicine Sales by Type
8.3 Middle East & Africa Ophthalmic Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Medicine
10.3 Manufacturing Process Analysis of Ophthalmic Medicine
10.4 Industry Chain Structure of Ophthalmic Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Medicine Distributors
11.3 Ophthalmic Medicine Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC MEDICINE BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Medicine Market Size Forecast by Region
12.1.1 Global Ophthalmic Medicine Forecast by Region (2024-2029)
12.1.2 Global Ophthalmic Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Medicine Forecast by Type
12.7 Global Ophthalmic Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novaliq
13.1.1 Novaliq Company Information
13.1.2 Novaliq Ophthalmic Medicine Product Portfolios and Specifications
13.1.3 Novaliq Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novaliq Main Business Overview
13.1.5 Novaliq Latest Developments
13.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
13.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
13.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolios and Specifications
13.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
13.3 Zhejiang Shapuaisi Pharmaceutical
13.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
13.3.2 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolios and Specifications
13.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhejiang Shapuaisi Pharmaceutical Main Business Overview
13.3.5 Zhejiang Shapuaisi Pharmaceutical Latest Developments
13.4 Chengdu Kanghong Pharmaceutical Group
13.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.4.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolios and Specifications
13.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.4.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
13.5 Santen Pharmaceutica
13.5.1 Santen Pharmaceutica Company Information
13.5.2 Santen Pharmaceutica Ophthalmic Medicine Product Portfolios and Specifications
13.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Santen Pharmaceutica Main Business Overview
13.5.5 Santen Pharmaceutica Latest Developments
13.6 Bausch Health
13.6.1 Bausch Health Company Information
13.6.2 Bausch Health Ophthalmic Medicine Product Portfolios and Specifications
13.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bausch Health Main Business Overview
13.6.5 Bausch Health Latest Developments
13.7 Alcon NV
13.7.1 Alcon NV Company Information
13.7.2 Alcon NV Ophthalmic Medicine Product Portfolios and Specifications
13.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Alcon NV Main Business Overview
13.7.5 Alcon NV Latest Developments
13.8 Mentholatum
13.8.1 Mentholatum Company Information
13.8.2 Mentholatum Ophthalmic Medicine Product Portfolios and Specifications
13.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mentholatum Main Business Overview
13.8.5 Mentholatum Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmic Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Ophthalmic Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Eye Drops
Table 4. Major Players of Eye Ointment
Table 5. Major Players of Gelling Agent
Table 6. Major Players of Tablet
Table 7. Major Players of Injection
Table 8. Global Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 9. Global Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Table 10. Global Ophthalmic Medicine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Ophthalmic Medicine Revenue Market Share by Type (2018-2023)
Table 12. Global Ophthalmic Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 14. Global Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Table 15. Global Ophthalmic Medicine Revenue by Application (2018-2023)
Table 16. Global Ophthalmic Medicine Revenue Market Share by Application (2018-2023)
Table 17. Global Ophthalmic Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Ophthalmic Medicine Sales by Company (2018-2023) & (K Units)
Table 19. Global Ophthalmic Medicine Sales Market Share by Company (2018-2023)
Table 20. Global Ophthalmic Medicine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Ophthalmic Medicine Revenue Market Share by Company (2018-2023)
Table 22. Global Ophthalmic Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Ophthalmic Medicine Producing Area Distribution and Sales Area
Table 24. Players Ophthalmic Medicine Products Offered
Table 25. Ophthalmic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Ophthalmic Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Ophthalmic Medicine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Ophthalmic Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Ophthalmic Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Ophthalmic Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Ophthalmic Medicine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Ophthalmic Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Ophthalmic Medicine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 37. Americas Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 38. Americas Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 40. Americas Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 41. Americas Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 42. APAC Ophthalmic Medicine Sales by Region (2018-2023) & (K Units)
Table 43. APAC Ophthalmic Medicine Sales Market Share by Region (2018-2023)
Table 44. APAC Ophthalmic Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Ophthalmic Medicine Revenue Market Share by Region (2018-2023)
Table 46. APAC Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 47. APAC Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 48. Europe Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 49. Europe Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 50. Europe Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 52. Europe Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 53. Europe Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Ophthalmic Medicine
Table 61. Key Market Challenges & Risks of Ophthalmic Medicine
Table 62. Key Industry Trends of Ophthalmic Medicine
Table 63. Ophthalmic Medicine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Ophthalmic Medicine Distributors List
Table 66. Ophthalmic Medicine Customer List
Table 67. Global Ophthalmic Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Ophthalmic Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Ophthalmic Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Ophthalmic Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Ophthalmic Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Ophthalmic Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Ophthalmic Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Ophthalmic Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Novaliq Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 82. Novaliq Ophthalmic Medicine Product Portfolios and Specifications
Table 83. Novaliq Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Novaliq Main Business
Table 85. Novaliq Latest Developments
Table 86. Shenyang Xingqi Pharmaceutical Co.,Ltd. Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 87. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolios and Specifications
Table 88. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business
Table 90. Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
Table 91. Zhejiang Shapuaisi Pharmaceutical Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 92. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolios and Specifications
Table 93. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Zhejiang Shapuaisi Pharmaceutical Main Business
Table 95. Zhejiang Shapuaisi Pharmaceutical Latest Developments
Table 96. Chengdu Kanghong Pharmaceutical Group Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 97. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolios and Specifications
Table 98. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Chengdu Kanghong Pharmaceutical Group Main Business
Table 100. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 101. Santen Pharmaceutica Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 102. Santen Pharmaceutica Ophthalmic Medicine Product Portfolios and Specifications
Table 103. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Santen Pharmaceutica Main Business
Table 105. Santen Pharmaceutica Latest Developments
Table 106. Bausch Health Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 107. Bausch Health Ophthalmic Medicine Product Portfolios and Specifications
Table 108. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Bausch Health Main Business
Table 110. Bausch Health Latest Developments
Table 111. Alcon NV Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 112. Alcon NV Ophthalmic Medicine Product Portfolios and Specifications
Table 113. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Alcon NV Main Business
Table 115. Alcon NV Latest Developments
Table 116. Mentholatum Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 117. Mentholatum Ophthalmic Medicine Product Portfolios and Specifications
Table 118. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Mentholatum Main Business
Table 120. Mentholatum Latest Developments
Table 1. Ophthalmic Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Ophthalmic Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Eye Drops
Table 4. Major Players of Eye Ointment
Table 5. Major Players of Gelling Agent
Table 6. Major Players of Tablet
Table 7. Major Players of Injection
Table 8. Global Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 9. Global Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Table 10. Global Ophthalmic Medicine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Ophthalmic Medicine Revenue Market Share by Type (2018-2023)
Table 12. Global Ophthalmic Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 14. Global Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Table 15. Global Ophthalmic Medicine Revenue by Application (2018-2023)
Table 16. Global Ophthalmic Medicine Revenue Market Share by Application (2018-2023)
Table 17. Global Ophthalmic Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Ophthalmic Medicine Sales by Company (2018-2023) & (K Units)
Table 19. Global Ophthalmic Medicine Sales Market Share by Company (2018-2023)
Table 20. Global Ophthalmic Medicine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Ophthalmic Medicine Revenue Market Share by Company (2018-2023)
Table 22. Global Ophthalmic Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Ophthalmic Medicine Producing Area Distribution and Sales Area
Table 24. Players Ophthalmic Medicine Products Offered
Table 25. Ophthalmic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Ophthalmic Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Ophthalmic Medicine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Ophthalmic Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Ophthalmic Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Ophthalmic Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Ophthalmic Medicine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Ophthalmic Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Ophthalmic Medicine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 37. Americas Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 38. Americas Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 40. Americas Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 41. Americas Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 42. APAC Ophthalmic Medicine Sales by Region (2018-2023) & (K Units)
Table 43. APAC Ophthalmic Medicine Sales Market Share by Region (2018-2023)
Table 44. APAC Ophthalmic Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Ophthalmic Medicine Revenue Market Share by Region (2018-2023)
Table 46. APAC Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 47. APAC Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 48. Europe Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 49. Europe Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 50. Europe Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 52. Europe Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 53. Europe Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Ophthalmic Medicine Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Ophthalmic Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Ophthalmic Medicine Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Ophthalmic Medicine Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Ophthalmic Medicine
Table 61. Key Market Challenges & Risks of Ophthalmic Medicine
Table 62. Key Industry Trends of Ophthalmic Medicine
Table 63. Ophthalmic Medicine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Ophthalmic Medicine Distributors List
Table 66. Ophthalmic Medicine Customer List
Table 67. Global Ophthalmic Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Ophthalmic Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Ophthalmic Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Ophthalmic Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Ophthalmic Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Ophthalmic Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Ophthalmic Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Ophthalmic Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Ophthalmic Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Ophthalmic Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Novaliq Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 82. Novaliq Ophthalmic Medicine Product Portfolios and Specifications
Table 83. Novaliq Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Novaliq Main Business
Table 85. Novaliq Latest Developments
Table 86. Shenyang Xingqi Pharmaceutical Co.,Ltd. Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 87. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolios and Specifications
Table 88. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business
Table 90. Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
Table 91. Zhejiang Shapuaisi Pharmaceutical Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 92. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolios and Specifications
Table 93. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Zhejiang Shapuaisi Pharmaceutical Main Business
Table 95. Zhejiang Shapuaisi Pharmaceutical Latest Developments
Table 96. Chengdu Kanghong Pharmaceutical Group Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 97. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolios and Specifications
Table 98. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Chengdu Kanghong Pharmaceutical Group Main Business
Table 100. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 101. Santen Pharmaceutica Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 102. Santen Pharmaceutica Ophthalmic Medicine Product Portfolios and Specifications
Table 103. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Santen Pharmaceutica Main Business
Table 105. Santen Pharmaceutica Latest Developments
Table 106. Bausch Health Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 107. Bausch Health Ophthalmic Medicine Product Portfolios and Specifications
Table 108. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Bausch Health Main Business
Table 110. Bausch Health Latest Developments
Table 111. Alcon NV Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 112. Alcon NV Ophthalmic Medicine Product Portfolios and Specifications
Table 113. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Alcon NV Main Business
Table 115. Alcon NV Latest Developments
Table 116. Mentholatum Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 117. Mentholatum Ophthalmic Medicine Product Portfolios and Specifications
Table 118. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Mentholatum Main Business
Table 120. Mentholatum Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ophthalmic Medicine
Figure 2. Ophthalmic Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Ophthalmic Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Ophthalmic Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Eye Drops
Figure 10. Product Picture of Eye Ointment
Figure 11. Product Picture of Gelling Agent
Figure 12. Product Picture of Tablet
Figure 13. Product Picture of Injection
Figure 14. Global Ophthalmic Medicine Sales Market Share by Type in 2022
Figure 15. Global Ophthalmic Medicine Revenue Market Share by Type (2018-2023)
Figure 16. Ophthalmic Medicine Consumed in Anti-fatigue and Dryness
Figure 17. Global Ophthalmic Medicine Market: Anti-fatigue and Dryness (2018-2023) & (K Units)
Figure 18. Ophthalmic Medicine Consumed in Cataract
Figure 19. Global Ophthalmic Medicine Market: Cataract (2018-2023) & (K Units)
Figure 20. Ophthalmic Medicine Consumed in Anti-infective
Figure 21. Global Ophthalmic Medicine Market: Anti-infective (2018-2023) & (K Units)
Figure 22. Global Ophthalmic Medicine Sales Market Share by Application (2022)
Figure 23. Global Ophthalmic Medicine Revenue Market Share by Application in 2022
Figure 24. Ophthalmic Medicine Sales Market by Company in 2022 (K Units)
Figure 25. Global Ophthalmic Medicine Sales Market Share by Company in 2022
Figure 26. Ophthalmic Medicine Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Ophthalmic Medicine Revenue Market Share by Company in 2022
Figure 28. Global Ophthalmic Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Ophthalmic Medicine Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 31. Americas Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 32. APAC Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 33. APAC Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 34. Europe Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 35. Europe Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 38. Americas Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 39. Americas Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 40. Americas Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 41. Americas Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 42. United States Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Ophthalmic Medicine Sales Market Share by Region in 2022
Figure 47. APAC Ophthalmic Medicine Revenue Market Share by Regions in 2022
Figure 48. APAC Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 49. APAC Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 50. China Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 58. Europe Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 59. Europe Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 60. Europe Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 61. Germany Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 70. Egypt Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Ophthalmic Medicine in 2022
Figure 76. Manufacturing Process Analysis of Ophthalmic Medicine
Figure 77. Industry Chain Structure of Ophthalmic Medicine
Figure 78. Channels of Distribution
Figure 79. Global Ophthalmic Medicine Sales Market Forecast by Region (2024-2029)
Figure 80. Global Ophthalmic Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Ophthalmic Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Ophthalmic Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Ophthalmic Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Ophthalmic Medicine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Ophthalmic Medicine
Figure 2. Ophthalmic Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Ophthalmic Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Ophthalmic Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Eye Drops
Figure 10. Product Picture of Eye Ointment
Figure 11. Product Picture of Gelling Agent
Figure 12. Product Picture of Tablet
Figure 13. Product Picture of Injection
Figure 14. Global Ophthalmic Medicine Sales Market Share by Type in 2022
Figure 15. Global Ophthalmic Medicine Revenue Market Share by Type (2018-2023)
Figure 16. Ophthalmic Medicine Consumed in Anti-fatigue and Dryness
Figure 17. Global Ophthalmic Medicine Market: Anti-fatigue and Dryness (2018-2023) & (K Units)
Figure 18. Ophthalmic Medicine Consumed in Cataract
Figure 19. Global Ophthalmic Medicine Market: Cataract (2018-2023) & (K Units)
Figure 20. Ophthalmic Medicine Consumed in Anti-infective
Figure 21. Global Ophthalmic Medicine Market: Anti-infective (2018-2023) & (K Units)
Figure 22. Global Ophthalmic Medicine Sales Market Share by Application (2022)
Figure 23. Global Ophthalmic Medicine Revenue Market Share by Application in 2022
Figure 24. Ophthalmic Medicine Sales Market by Company in 2022 (K Units)
Figure 25. Global Ophthalmic Medicine Sales Market Share by Company in 2022
Figure 26. Ophthalmic Medicine Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Ophthalmic Medicine Revenue Market Share by Company in 2022
Figure 28. Global Ophthalmic Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Ophthalmic Medicine Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 31. Americas Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 32. APAC Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 33. APAC Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 34. Europe Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 35. Europe Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Ophthalmic Medicine Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Ophthalmic Medicine Revenue 2018-2023 ($ Millions)
Figure 38. Americas Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 39. Americas Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 40. Americas Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 41. Americas Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 42. United States Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Ophthalmic Medicine Sales Market Share by Region in 2022
Figure 47. APAC Ophthalmic Medicine Revenue Market Share by Regions in 2022
Figure 48. APAC Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 49. APAC Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 50. China Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 58. Europe Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 59. Europe Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 60. Europe Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 61. Germany Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Ophthalmic Medicine Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Ophthalmic Medicine Sales Market Share by Application (2018-2023)
Figure 70. Egypt Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Ophthalmic Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Ophthalmic Medicine in 2022
Figure 76. Manufacturing Process Analysis of Ophthalmic Medicine
Figure 77. Industry Chain Structure of Ophthalmic Medicine
Figure 78. Channels of Distribution
Figure 79. Global Ophthalmic Medicine Sales Market Forecast by Region (2024-2029)
Figure 80. Global Ophthalmic Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Ophthalmic Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Ophthalmic Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Ophthalmic Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Ophthalmic Medicine Revenue Market Share Forecast by Application (2024-2029)
